Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY
Journal: Arthritis Research & Therapy
Year: 2016

ClinicalTrials.gov, NCT01061736 , February 2, 2010.